Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

24.24CNY
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
¥24.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,456,232
52-wk High
¥29.25
52-wk Low
¥20.81

Latest Key Developments (Source: Significant Developments)

Shanghai Pharmaceuticals Says Unit And Sure Advance Holdings Enter Investment Agreement
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SHANGHAI PHARMACEUTICALS (HK) AND SURE ADVANCE HOLDINGS ENTERED INTO A INVESTMENT AGREEMENT WITH CHINA ISOTOPE , CICC AND CLSA.SHANGHAI PHARMACEUTICALS (HK) AND SURE ADVANCE PARTICIPATED IN INITIAL PUBLIC OFFERINGS OF CHINA ISOTOPE.SURE ADVANCE HOLDINGS CONTRIBUTES NEARLY NO MORE THAN RMB 430 MILLION TO SUBSCRIBE FOR SHARES OF CHINA ISOTOPE.ESTIMATES SUBSCRIPTION PRICE PAYABLE BY UNIT UNDER CORNERSTONE INVESTMENT DEAL FOR INVESTOR SHARES TO NOT EXCEED RMB160 MILLION.  Full Article

Shanghai Pharmaceuticals' Unit To Subscribe Shares Of China Isotope & Radiation's Hong Kong IPO
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS UNIT PLANS TO INVEST UP TO 160 MILLION YUAN ($24.70 million) TO SUBSCRIBE SHARES OF CHINA ISOTOPE & RADIATION'S HONG KONG IPO.  Full Article

Shanghai Pharma To Acquire An Indirect Stake In Guangzhou's Techpool Bio-Pharma
Monday, 21 May 2018 

May 21 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS ITS HONG KONG UNIT PLANS TO ACQUIRE TAKEDA CHROMO BETEILIGUNGS AG TO INDIRECTLY OWN 26.34 PERCENT OF TECHPOOL BIO-PHARMA CO., LTD.SAYS TRANSACTION PRICE AT $144 MILLION.SAYS ITS DIRECT AND INDIRECT STAKES IN TECHPOOL BIO-PHARMA TO TOTAL AROUND 67.14 PERCENT AFTER THE DEAL.  Full Article

Shanghai Pharmaceuticals Holding and unit receive approval for drug clinical trial
Friday, 18 May 2018 

May 18(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says co and unit received approval for drug clinical trial for a kind of tablet SPH3348, from China Food and Drug Administration.Says the tablet is mainly used for tumour treatment .  Full Article

Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares
Monday, 26 Mar 2018 

March 26 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 5 Mar 2018 

March 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products .Says the valid period is until Feb. 5, 2023.  Full Article

Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 2607.HK::‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​.‍NET PROCEEDS FROM PLACING EXPECTED TO BE HK$3,116.79 MILLION​.PROCEEDS TO FUND DEVELOPMENT OF PHARMACEUTICAL MANUFACTURING & DISTRIBUTION BUSINESSES & REPLENISH ITS WORKING CAPITAL​.  Full Article

Shanghai Pharmaceuticals Holding units receive GMP certificate
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line .Says the valid period is until Dec. 25, 2022.Says Shanghai-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for its products including flurbiprofen axetil .Says the valid period is until Dec. 26, 2022 .  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug .Says the valid period is until Dec. 25, 2022.  Full Article

Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​.  Full Article